Form 4: Oscar Health CFO Sells Shares Under 10b5-1 Plan

Oscar Health's Chief Financial Officer, Richard Scott Blackley, has sold a significant number of Class A common stock shares as part of a pre-arranged trading plan.

Summary

• Richard Scott Blackley, Chief Financial Officer of Oscar Health, Inc., reported a transaction involving the sale of 110,000 shares of Class A Common Stock on May 18, 2026.
• The sale was executed under a Rule 10b5-1 trading plan adopted on February 12, 2026, which is designed to comply with affirmative defense conditions.
• The shares were sold at a weighted average price of $25.03, with individual transactions ranging from $25.00 to $25.20.
• Following this transaction, Blackley beneficially owns 1,106,660 shares of Class A Common Stock, with 75,000 shares held indirectly through the MQB Irrevocable Trust.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative sentiment due to the significant sale by a key executive, despite the transaction being part of a pre-arranged plan.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, indicating adherence to pre-determined trading strategies and regulatory compliance.
• The sale occurred at a weighted average price of $25.03, suggesting a stable market price at the time of the transaction.
• The reporting person retains a substantial beneficial ownership of 1,106,660 shares, indicating continued investment in the company.

Negatives

• A significant number of shares (110,000) were sold by a key executive, which could be perceived negatively by the market.
• The sale represents a reduction in direct beneficial ownership by the CFO.

Risks

• The sale of a large number of shares by an executive could signal a lack of confidence in future stock performance, although it was executed under a pre-planned trading strategy.
• The weighted average sale price of $25.03 might be lower than future anticipated prices, representing a missed opportunity for the seller if the stock price increases.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The transaction was executed under a pre-existing trading plan.

Management Comments

• The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2026.
• The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Industry Context

StockSavvy.ai notes that insider sales, even under Rule 10b5-1 plans, are closely watched by investors. While these plans are designed to avoid signaling, significant sales by C-suite executives can sometimes influence market perception, especially in the health insurance technology sector which is highly sensitive to regulatory changes and competitive pressures.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the sale by the CFO with caution, potentially impacting short-term stock price sentiment, although the Rule 10b5-1 plan mitigates direct signaling concerns.
• Employees: May interpret the sale as a sign of executive confidence or a need for personal liquidity, depending on broader company performance.
• Creditors: Unlikely to be directly impacted by this specific insider transaction.

Next Steps

• The reporting person may continue to execute trades under the Rule 10b5-1 plan.
• The company may provide further financial updates in subsequent filings.

Key Dates

Recommendation

The filing reports an insider sale under a Rule 10b5-1 plan, which is a standard compliance mechanism. While a large sale by a CFO can be a negative signal, the pre-planned nature reduces its direct interpretability as a lack of confidence. The company's overall financial health and future prospects, not detailed in this specific filing, would be the primary drivers for a buy/sell/hold decision. Therefore, a 'hold' recommendation is appropriate pending further information.

Keywords

Oscar Health, OSCR, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Richard Scott Blackley, Chief Financial Officer, Class A Common Stock, Beneficial Ownership